Fact CheckerSign in

NCT06143397Completed

Effect of TTNS and PNS on Neurogenic Overactive Bladder Symptoms in Female Patients With Multiple Sclerosis.

Effect of Transcutaneous Posterior Tibial Nerve Stimulation and Parasacral Transcutaneous Electrical Stimulation on Neurogenic Overactive Bladder Symptoms in Female Patients With Multiple Sclerosis.

Source: ClinicalTrials.gov · Last updated 4 Dec 2025

Brief summary (registry, in English)

This study aims to evaluate the use of transcutaneous tibial nerve stimulation (TTNS) and parasacral nerve stimulation (PSS) methods in the treatment of overactive bladder (OAB) symptoms in patients with Multiple Sclerosis (MS), including urination frequency, urgency, urinary incontinence, post-void residue, maximum micturition rate. To investigate the effect on parameters such as voiding volume and quality of life and to compare the final results between groups.

Status (registry)
Completed
Study type
Interventional
Enrollment
42 (actual)
First submitted
16 Nov 2023
Start date
20 Nov 2023
Primary completion date
20 Oct 2025
Lead sponsor
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
NCT number
NCT06143397

What you commit to

  • Study type: Interventional
  • Participants enrolled: 42
  • From 20 Nov 2023 to the primary completion date, 20 Oct 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients using diuretic drugs or patients with a clean intermittent catheter

Other illness

  • Patients with urinary tract infections
  • Patients diagnosed with diabetes mellitus
  • Patients with a history of different urological diseases
  • Patients with heart or brain pacemaker users, those with epilepsy, and patients with language and cognitive limitations

Other

  • Patients who are pregnant or in the postpartum period
  • Lack of activity performance for 2 weeks (regardless of which group)

Who the study is looking for

  • Having symptoms related to overactive bladder (OAB-v8 score ⩾8),
  • Over 18 years of age
  • No relapse for at least 1 month
  • All types of MS, including those with relapses
  • Female MS patients with an Expanded Disability Status Scale (EDSS) score below 7.0
  • Agreeing to participate in the research

Age in the registry: 18 years to 65 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Prof.Dr.Cemil Taşcıoğlu Şehir Hastanesi
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.